Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that a ...
Analysts say this fundamental shift will likely persist even if the Iran war ends and may ultimately strengthen China's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results